AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI — Stella

Home/HER2 Positive Breast Carcinoma/

View on ClinicalTrials.gov

Recruiting

Back to HER2 Positive Breast Carcinoma trials

Trial locations(1 site)

Germany

Department of Diagnostic and Interventional Radiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Düsseldorf, North Rhine-Westphalia

Key details

Sponsor

Heinrich-Heine University, Duesseldorf

Collaborators

University Hospital, Essen, Marienhospital Bottrop

Enrollment target

~460 participants

Started

July 2025

Primary completion

March 2031

Age range

18 Years and older

Sex

Female only

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.